Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities.
Cruz-Valdez A, Palacio-Mejía LS, Quezada-Sánchez AD, Hernández-Ávila JE, Galicia-Carmona T, Cetina-Pérez LDC, Arango-Bravo EA, Isla-Ortiz D, Aranda-Flores CE, Uscanga-Sánchez SR, Madrid-Marina V, Torres-Poveda K. Cruz-Valdez A, et al. Among authors: cetina perez ldc. Front Oncol. 2023 Mar 9;13:1008560. doi: 10.3389/fonc.2023.1008560. eCollection 2023. Front Oncol. 2023. PMID: 36969022 Free PMC article.
STANDARD TREATMENT WITH BEVACIZUMAB AS TARGETED THERAPY IN CERVICAL CANCER.
Enríquez-Aceves I, Galicia-Carmona T, Coronel-Martínez JA, Espinosa-Romero R, Calderillo-Ruíz G, Cortés-Esteban P, Cetina-Pérez L. Enríquez-Aceves I, et al. Rev Invest Clin. 2020;72(4):213-218. doi: 10.24875/RIC.20000061. Rev Invest Clin. 2020. PMID: 33064702 Free article. Review.
IMMUNOTHERAPY TREATMENT AGAINST CERVICAL CANCER.
Jiménez-Lima R, Arango-Bravo E, Galicia-Carmona T, Lino-Silva LS, Trejo-Durán GE, Alvarado-Silva C, Castañeda-Renderos OH, Vanoye-Carlo EG, Torre CF, Dueñas-González A, Cetina-Pérez L. Jiménez-Lima R, et al. Rev Invest Clin. 2020;72(4):231-238. doi: 10.24875/RIC.20000060. Rev Invest Clin. 2020. PMID: 33064705 Free article. Review.
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer.
Galicia-Carmona T, Arango-Bravo E, Serrano-Olvera JA, Flores-de La Torre C, Cruz-Esquivel I, Villalobos-Valencia R, Morán-Mendoza A, Castro-Eguiluz D, Cetina-Pérez L. Galicia-Carmona T, et al. Hum Vaccin Immunother. 2021 Aug 3;17(8):2617-2625. doi: 10.1080/21645515.2021.1893036. Epub 2021 Apr 1. Hum Vaccin Immunother. 2021. PMID: 33793380 Free PMC article.
The health system and access to treatment in patients with cervical cancer in Mexico.
Arango-Bravo EA, Cetina-Pérez LDC, Galicia-Carmona T, Castro-Eguiluz D, Gallardo-Rincón D, Cruz-Bautista I, Duenas-Gonzalez A. Arango-Bravo EA, et al. Among authors: cetina perez ldc. Front Oncol. 2022 Nov 30;12:1028291. doi: 10.3389/fonc.2022.1028291. eCollection 2022. Front Oncol. 2022. PMID: 36530977 Free PMC article. Review.
Chemoradiotherapy treatment with gemcitabine improves renal function in locally advanced cervical cancer patients with renal dysfunction.
Alarcón-Barrios S, Luvián-Morales J, Castro-Eguiluz D, Delgadillo-González M, Lezcano-Velázquez BO, Arango-Bravo EA, Flores-Cisneros L, Aguiar Rosas S, Cetina-Pérez L. Alarcón-Barrios S, et al. Curr Probl Cancer. 2024 Feb;48:101041. doi: 10.1016/j.currproblcancer.2023.101041. Epub 2023 Nov 20. Curr Probl Cancer. 2024. PMID: 37988902
34 results